Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OrbiMed
Biotech
Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic
Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured $140 million in series A funds.
James Waldron
Dec 19, 2024 6:58am
Novo Holdings-backed SiteOne charges up with $100M financing
Dec 18, 2024 7:00am
ADC biotech adds on $135M series B
Nov 25, 2024 7:00am
Alentis raises $181M series D to bring ADCs to the clinic
Nov 12, 2024 7:00am
Capitalizing on ADC frenzy, ProfoundBio attracts $112M series B
Feb 13, 2024 7:00am
Flagship CEO says firm has work to do before inking China pacts
Jan 8, 2024 9:05pm
